Amgen's dividend shows stronger growth and safety than Merck's despite similar yields.

Amgen and Merck both offer dividends around 2.3%, but Amgen's dividend is more secure and has better growth prospects. Amgen covers its dividend with less than half of its earnings and has a strong cash flow and growth in key products, while Merck's dividend payout exceeds its current earnings and relies on future pipeline success. Amgen also raises its dividend faster and shows more immediate revenue growth, making it a stronger choice for income investors focused on dividend safety and growth.

As of Oct 16, 2026 00:02 WIB, Amgen trades at USD 439.85 with a dividend yield of 2.37% on Pluang, slightly above Merck's 2.31%. Amgen's shares have gained 3.22% in the last day, outperforming Merck's 1.31% increase. Despite a higher market cap of $363.59B for Merck, Amgen's shorter typical hold time of 72 days suggests more active trading among Pluang users.